Psoriasis Drug Raptiva Pulled From U.S. Market
Links shared publicly online about this topic
Psoriasis drug Raptiva pulled from the market | Booster Shots | Los Angeles Times
latimesblogs.latimes.com — “The drug company Genentech pulled Raptiva from the U.S. market today -- read the Reuters story here, and the AP story here. Here is the FDA statement about the recall. And here's company information about the recall. It states, "Since...” View full resource at latimesblogs.latimes.com
Most Recently Shared on April 9, 2009 at 12:25 am By:
LA Times Health News Health News
Psoriasis drug Raptiva pulled from the market : The drug company Genentech pulled Raptiva from the U.S. market t.. http://tinyurl.com/cr7xrw
Genentech Pulls Raptiva Psoriasis Drug - WSJ.com
online.wsj.com — “Genentech is voluntarily withdrawing its psoriasis drug Raptiva from the market after it was linked with a rare but often fatal brain disorder.” View full resource at online.wsj.com
Most Recently Shared on April 9, 2009 at 5:51 am By:
Warning for psoriasis drug users/prescribers: Raptiva pulled due to linked rare but often fatal brain disorder: http://tinyurl.com/cjaxxx
Genentech Pulls Raptiva Psoriasis Drug - WSJ.com
feeds.wsjonline.com — “Genentech is voluntarily withdrawing its psoriasis drug Raptiva from the market after it was linked with a rare but often fatal brain disorder.” View full resource at feeds.wsjonline.com
Most Recently Shared on April 8, 2009 at 10:23 pm By:
Genentech to Pull Raptiva Over Fears http://tinyurl.com/dx23sr
Makers of Raptiva Remove Psoriasis Drug From Market Due to PML Risks
usrecallnews.com — “Genentech, makers of the psoriasis drug Raptiva (efalizumab) have announced a voluntary withdrawal of the drug from the US market after learning of a rare but serious risk to patients taking the drug.” View full resource at usrecallnews.com
Most Recently Shared on April 8, 2009 at 10:51 pm By:
New Recall Alert: Makers of Raptiva Remove Psoriasis Drug From Market Due to PML Risks http://tinyurl.com/cant5q
Genentech, Inc. Pulls Psoriasis Drug Raptiva from Market for Safety - News, Search Jobs, Events
biospace.com — “Genentech, Inc. Pulls Psoriasis Drug Raptiva from Market for Safety - News, Search Jobs, Events” View full resource at biospace.com
Most Recently Shared on April 8, 2009 at 10:33 pm By:
Wendy Blackburn Health Executive
RT @BioSpace365: Genentech withdraws psoriasis drug Raptiva from market for safety http://ow.ly/2ojN
Voluntary Withdrawal of Raptiva - MPR
empr.com — “Genentech announced a voluntary withdrawal of the psoriasis drug Raptiva (efalizumab) from the U.S. market.” View full resource at empr.com
Most Recently Shared on April 8, 2009 at 10:48 pm By:
MPR News: Voluntary Withdrawal of Raptiva: Genentech announced a voluntary withdrawal of the psoriasis .. http://tinyurl.com/dzymh2
Medical News: Raptiva Yanked from U.S. Market - in Product Alert, Prescriptions from MedPage Today
medpagetoday.com — “WHEELING, W.Va. -- The psoriasis drug efalizumab (Raptiva) will be removed from the U.S. market because of the risk of progressive multifocal leukoencephalopathy (PML), its manufacturer said today.” View full resource at medpagetoday.com
Most Recently Shared on April 9, 2009 at 11:42 am By:
Efalizumab Yanked from U.S. Market http://medpagetoday.com/13666
Medicine and Technology [part of HCPLive]: FDA: Raptiva Voluntary Withdrawal
medicineandtechnology.com — “Medicine and Technology [part of HCPLive]: FDA: Raptiva Voluntary Withdrawal” View full resource at medicineandtechnology.com
Most Recently Shared on May 27, 2009 at 11:32 pm By:
Joseph Kim, MD, MPH Doctor and Physician
@BodyNHealth Lots of concern over the safety of biologics because of Raptiva. FDA has been slow to approve new drugs http://bit.ly/11fpdH
Health and Medical News - myOptumHealth
myoptumhealth.com — “Find health news headlines and health articles on weight loss, medications, diseases, aging, fitness and more at www.myOptumHealth.com.” View full resource at myoptumhealth.com
Most Recently Shared on April 9, 2009 at 4:48 am By:
Psoriasis Drug Raptiva Pulled From U.S. Market: Drug manufacturer acts after link found to rare brain infection http://tinyurl.com/d5ndyz
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
LA Times Health News
Current health + medical news from the Los Angeles Times + latimes.com. See latimes.com/twitter for more news + features streams.
-
myGeneticist
The inside tweets from a pharmacogenomics startup.
-
WSJ Health
Health news coverage from the Wall Street Journal
Advertisement
